SK pharmteco’s innovative LentiSure™ and AAVelocity™ platforms are transforming the cell and gene therapy landscape. This technical piece highlights scalable, plug-and-play solutions that achieve consistent high titers and rapid clinical batch releases within 12 months. Learn about advanced analytical capabilities, streamlined assay development, and proven success across over 100 batches produced. Download now to explore how these platforms address critical challenges in viral vector manufacturing and accelerate advanced therapy development.